Cart
sales@molnova.com
Cl-C6-PEG4-O-CH2COOH
CAS No. 1799506-30-1
Cl-C6-PEG4-O-CH2COOH( —— )
Catalog No. M33556 CAS No. 1799506-30-1
Cl-C6-PEG4-O-CH2COOH (PROTAC Linker 4) is an efficient pegylated PROTAC linker commonly used in the synthesis of chloroanes (HaloPROTACs).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 29 | In Stock |
|
| 10MG | 39 | In Stock |
|
| 25MG | 62 | In Stock |
|
| 50MG | 98 | In Stock |
|
| 100MG | 157 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 393 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCl-C6-PEG4-O-CH2COOH
-
NoteResearch use only, not for human use.
-
Brief DescriptionCl-C6-PEG4-O-CH2COOH (PROTAC Linker 4) is an efficient pegylated PROTAC linker commonly used in the synthesis of chloroanes (HaloPROTACs).
-
DescriptionCl-C6-PEG4-O-CH2COOH (PROTAC Linker 4) is a PEG-based PROTAC linker can be used in the synthesis of chloroalkane-containing PROTACs (HaloPROTACs).
-
In VitroPROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1799506-30-1
-
Formula Weight370.87
-
Molecular FormulaC16H31ClO7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?Ethanol : 100 mg/mL (269.64 mM; Ultrasonic)DMSO : 100 mg/mL (269.64 mM; Ultrasonic )
-
SMILESC(OCCOCCOCCCCCCCl)COCCOCC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Buckley DL, et al.HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins. ACS Chem Biol. 2015 Aug 21;10(8):1831-7.?
molnova catalog
related products
-
FDC - SP (30 - 85), ...
FDC - SP (30 - 85), human
-
Dasatinib N-oxide
Dasatinib N-oxide is a major metabolite of the Abl and Src kinase inhibitor dasatinib.It is also a potential impurity in commercial preparations of dasatinib.
-
TPI-1
TPI-1 is a SHP-1 inhibitor.
